Table 3 Antibiotic susceptibilities of different blood culture isolates
Antibiotics | Enterococcus faecium | Escherichia coli | Klebsiella pneumonia | Pseudomonas aeruginosa | Acinetobacter baumannii | Enterobacter cloacae |
|---|---|---|---|---|---|---|
Aamikacin | – | 100%(11/11) | 100%(5/5) | 40%(2/5) | – | 100%(4/4) |
Ampicillin | 8%(1/12) | 14%(1/7) | 0%(0/4) | 0%(0/5) | 0%(0/4) | 0%(0/2) |
Aztreonam | – | 38%(3/8) | 100%(4/4) | 50%(2/4) | 0%(0/3) | 50%(1/2) |
Nitrofurantoin | 33%(4/12) | 63%(5/8) | 50%(2/4) | 0%(0/3) | 0%(0/3) | 50%(1/2) |
Ciprofloxacin | 0%(0/12) | 27%(3/11) | 80%(4/5) | 60%(3/5) | 0%(0/4) | 100%(4/4) |
Gentamicin | 38%(3/8) | 75%(6/8) | 100%(4/4) | 33%(1/3) | 33%(1/3) | 100%(2/2) |
Cefazolin | – | 0%(0/6) | 0%(0/4) | 0%(0/3) | 0%(0/3) | 0%(0/2) |
Ceftazidime | – | 45%(5/11) | 80%(4/5) | 60%(3/5) | 0%(0/4) | 25%(1/4) |
Ceftriaxone | – | 38%(3/8) | 75%(3/4) | 0%(0/3) | 0%(0/3) | 50%(1/2) |
Cefepime | – | 64%(7/11) | 80%(4/5) | 40%(2/5) | 0%(0/4) | 75%(3/4) |
Vancomycin | 100%(12/12) | – | – | – | – | – |
Linezolid | 100%(12/12) | – | – | – | – | – |
Imipenem | – | 100%(11/11) | 100%(5/5) | 20%(1/5) | 0%(0/4) | 100%(4/4) |
Levofloxacin | 0%(0/8) | 29%(2/7) | 100%(4/4) | 60%(3/5) | 0%(0/3) | 100%(2/2) |